No Detail Found!

Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment

Author(s)
Shuang Sun College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Qingxia Guan College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Eryu Shang Fire Control Room, Heilongjiang Forest Protection Institute,Harbin,China
Hongbin Xiao College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Xin Yu College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Lei Shi College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Chengcheng Zhao College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Yuyan Guo College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Shaowa Lv College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Yongji Li College of Pharmacy, Heilongjiang University of Chinese Medicine,Harbin,China
Abstract
This study aimed to develop hyaluronic acid (HA)-coated nanostructured lipid carriers (NLC) loaded simultaneously with oleanolic acid (OA), ursolic acid (UA) and Ginsenoside Rg3 (Rg3), prepared by electrostatic attraction for delivering OA, UA and Rg3 (OUR), termed HA-OUR-NLC, to tumors over expressing cluster determinant 44(CD44). The dialysis method was used to assess the in vitro release of OUR. Parameters such as pharmacokinetics, biodistribution, fluorescence in vivo endo-microscopy (FIVE), optical in vivo imaging (OIVI) data, and in vivo antitumor effects were evaluated. The results showed a total drug loading rate of 8.76±0.95% for the optimized HA-OUR-NLC; total encapsulation efficiency was 45.67±1.14%; particle size was 165.15±3.84%; polydispersity index was 0.227±0.01; zeta potential was -22.87±0.97 mV. Drug release followed the Higuchi kinetics. Pharmacokinetics and tissue distribution, as well as antitumor effects were evaluated in nude mice in vivo. HA-OUR-NLC were better tolerated, with increased antitumor activity compared with 5-Fu. In in vivo optical imaging, we use 1,1'-dioctadecyl-3,3,3',3'-tetramethy(DiR) as a fluorescent dye to label the NLC. The DiR-OUR-NLC group showed bright systemic signals, while the tumor site was weak. The present findings indicated that HA-OUR-NLC accumulated in the tumor site, prolonging OUR duration in the circulation and enhancing tumoral concentrations. Therefore, NLC prepared by electrostatic attraction constitute a good system for delivering OUR to tumors.
Publication Details
Page(s) 109-119
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: 1, Year: 2020

Request the full text from PASTIC

Keywords
Tumor target, multiple components, Nanostructured lipid carriers, Fluorescence in vivo endo-microscopy (FIVE)
0

Citations

0

Downloads

61

Views